Dr. Chester is an Asst. Professor at the National University of Singapore and consultant cardiologist at the National University Hospital who cares for COVID-19 patients. He is a Singapore permanent resident and currently maintains both internal medicine and cardiology board certifications in the US and Singapore. Dr. Drum received an M.D. and Ph.D. from the University of Chicago.
He was trained in medicine at the University of California, San Diego and as a cardiologist at Brigham and Women’s Hospital (Harvard Medical School), in Boston. He then moved to Massachusetts Institute of Technology where he received the Burroughs Wellcome Career Award for Medical Scientists. In Singapore, he has been a recipient of ~7 million USD in grant awards including a Clinician Scientist Award from the NMRC, funding from the BMRC and multiple innovation awards from the Singapore MIT Alliance for Research and Technology (SMART). At National University Hospital in Singapore, Dr. Drum draws on his over 20 years of clinical experience in managed care, private, public and academic healthcare settings in the US and Asia to create novel analytics for predicting patient outcomes. Dr. Drum has multiple patents and oversees a large research facility and bioinformatics unit at NUH.
His current efforts are focused on the implementation of cost-beneficial precision medicine within NUH using advanced risk prediction models. Dr. Drum has been featured in the New York Times and has over 40 publications including journals such as Nature, Nature Communications, Journal of the American Heart Association, PNAS and Small in addition to featured editorial content in Science Translational Medicine.